For instance, by delivering sorafenib and CRISPR system via nanoparticles, Zhang et al.[108] achieved effective modification of EGFR, following synergistic inhibition of angiogenesis and tumor cell proliferation. This evidence concerns the gene EGFR and neoplasm.